AKT is one of downstream targets of EGFR pathway and there is correlation between high levels of NF-kB activation and EGFR overexpression in breast cancer (Biswas and Iglehart, 2006; Seshacharyulu et al., 2012). Here, NFKB1 is linked to breast cancer.